Inhalation of swine-house dust increases the concentrations of interleukin-1 beta (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) in peripheral blood  by Wang, Z. et al.
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SWINE DUST INDUCED RELEASE OF IL-I~~ AND IL-Q 1023 
allergy or asthma or had experienced respiratory infection 
within 2 weeks preceding the study. The mean FEV, was 
99.2% (range 71-126) and vital capacity (VC) 97.3% (range 
75-118) of predicted values. All subjects gave their 
informed consent and the local ethics committee approved 
the study. 
STUDY DESIGN 
Spirometry and measurement of bronchial responsiveness 
to methacholine were performed 3-14 days prior to expo- 
sure to swine dust. In the morning on the day of exposure, 
blood samples were drawn and oral temperature was 
measured. The subjects were then exposed for 3 h in a swine 
confinement building with approximately 700 swines weigh- 
ing approximately 100 kg each. During this time a selection 
of swine was guided through a weighing box, a procedure 
that caused considerable aerosolization of settled dust. 
Each subject carried personal dust samplers throughout the 
whole exposure period. 
Blood was drawn 3 h (n=8), 4 h (n=36), 7 h (n=36) and 
24 h (n=8) after the start of exposure. Spirometry and a 
methacholine bronchial provocation test were performed 
7 h after the start of exposure. The oral temperature was 
measured at 3, 5 and 7 h after the start of exposure and 
those who felt febrile or were uncertain about febrile 
symptoms continued to record their temperature at 9 and 
11 h after the start of exposure. 
LUNG FUNCTION AND BRONCHIAL 
RESPONSIVENESS 
FEV, and VC were measured according to the ATS criteria 
(8) with a low-resistance rolling-seal spirometer (OHIO 
model 840, Airco, Madison, WI, U.S.A.). Local reference 
values were used (9,lO). Bronchial responsiveness was 
measured with a methacholine provocation test. Inhalation 
of diluent was followed by doubling concentrations of 
methacholine starting at 0.5 mg ml- ’ until FEV, had 
decreased 20% compared to the value obtained after inha- 
lation of the diluent. The cumulative dose causing the 20% 
decrease in FEV, (PD,,FEV,) was calculated. The method 
is standardized with regard to inhalation flow (0.4 1 s- ‘), 
inhalation volume (0.8 l), and number of breaths. The 
details of the procedure have been described elsewhere (11). 
EXPOSURE MEASUREMENT 
Inhalable dust was sampled at an air flow of 1.9- 
2.0 1 min ~ ’ with personal samplers using 25 mm IOM head 
open-phase filter cassettes and IOM air suction pumps 
(SKC Ltd, Dorset, U.K.). The cassettes were carried in the 
breathing zone and were equipped with 0.4 mm polycar- 
bonate filters (Nuclepore@, Costar Corp Headquarters, 
Cambridge, MA, U.S.A.). Eight subjects carried Cyclone’cR: 
samplers (25 mm 8 mm Millipore SCWP) for measurement 
of the respirable dust fraction. Inhalable dust and respirable 
dust were measured by weighing after 24 h of conditioning, 
using a Mettler (@ ME22 balance (Mettler, Greisensee, 
Switzerland) and reference filters. Endotoxin in the inhal- 
able dust was measured after extraction in suitable dilution 
with a chromogen version of the limulus amebocyte lysate 
assay (CoA endotoxin test, Kabi Vitrum Diagnostic, 
Stockholm, Sweden, with Escherichia coli 0111 B4 as stan- 
dard). The method has been described in detail elsewhere 
u-v 
CYTOKINE ASSAYS IN SERUM 
IL-lra, IL-6 and TNF-a were analysed using commercial 
kits (Quantikine@ R&D systems, Europe Ltd, U.K.). 
IL-lra and IL-6 were determined using a sandwich enzyme 
immunoassay technique with a monoclonal antibody. The 
lowest standard for IL-lra and IL-6 were 46.9 and 
3.9 ng 1~ i, respectively. TNF-a was measured with the high 
sensitivity sandwich enzyme immunoassay method from 
the same source. The lowest standard was 0.5 ng 1 - i. All 
assays were done in duplicate. Samples with a coefficient of 
variation (CV) < 10% were not accepted. 
ISOLATION OF PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
Peripheral blood mononuclear cells (PBMC) were sepa- 
rated from sterile EDTA blood (4.5 ml, Becton Dickinson, 
San Jose, CA, U.S.A.) by centrifugation through 
Histopaque-1077 (Sigma Diagnostics, St. Louis, MO, 
U.S.A.) (n = 8) or Ficoll-Paque (Pharmacia, Uppsala, 
Sweden) (n=8). In the histopaque method 3 ml blood was 
applied on 3 ml histopaque in a polypropylene sterile 
conical centrifuge tube. In the Ficoll-Paque method 2 ml 
blood was mixed with 2 ml of balanced salt solution and 
applied on 3 ml of Ficoll-Paque in a sterile glass tube. 
Subsequent steps were identical in both methods. The 
samples were centrifuged at 400g for 40 min at room 
temperature. The interface cells were then harvested, mixed 
by gentle aspiration, washed twice with Hank’s balanced 
salt solution (Biochrom KG, Berlin) and centrifuged at 
250g for 10min. Two portions of each sample were 
prepared. 
One portion consisted of the washed cell pellet that was 
resuspended in 0.5 ml Hank’s solution (only histopaque 
separated blood, n = 8). A sample was spread on a film dried 
and stained with May-Griinwald-Giemsa stain. Five hun- 
dred to 700 cells were counted using light microscopy. The 
purity of the sample was checked and the total PBMC cell 
count and the proportion of lymphocytes and monocytes 
were counted. Viability of PBMC was determined with the 
trypan blue exclusion test and was more than 95%. 
The second sample consisted of the washed cell pellet 
resuspended in 3 ml Hank’s solution (Histo-Paque sample), 
or 2 ml Hank’s solution (Ficoll-Paque) and was stored in 
- 70°C. This sample was freeze-thawed two cycles to 
release intracellular IL-lp before analysis. 
PREPARATION OF PLATELET-POOR PLASMA 
Blood samples were collected in sterile vacuum blood collec- 
tion tubes containing EDTA. The tubes were centrifuged 
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immediately after venipuncture (400-g for 10 min). Plasma 
was removed without disturbing the buffy coat, aliquoted in 
1.5 ml microfuge tubes and was spun at 1600 g at 3000 rpm 
for 10 min to pellet the platelets. The platelet free plasma 
was transferred to 
assay. 
new microfuge tubes and frozen until 
IL-@ ASSAY IN PBMC AND PLASMA 
The concentration of IL-l@ in the freeze-thawed PBMC 
sample was measured in 16 subjects. In eight of these 
subjects extra blood samples were taken at 3 h and 24 h, in 
order to study the time course of IL-lb release. In the other 
eight subjects both the IL-ID in PBMC was measured and 
the proportion of monocytes in the PBMC fraction. 
IL-l/? was measured in platelet poor plasma (n=8) using 
the high sensitivity Quantikine@ commercial ELISA kit 
(Europe Ltd, U.K.). The lowest standard was 0.125 ng 1 - ‘. 
PERIPHERAL BLOOD CELL COUNTS 
Peripheral blood was collected using EDTA tubes and was 
rolled for 30 min. The sample was prepared using the 
COULTER Q-PREPS to obtain leukocytes with the cell 
surface markers CD451CD14 and was analysed using flow 
cytometry (EPICS@ PROFILE II, Coulter Electronic Ltd, 
Northwell Drive, Luton, Bedfordshire, U.K.). 
STATISTICAL ANALYSIS 
The results were analysed using Stat-View, 4.0 (Abacus 
concepts Inc). Wilcoxon’s signed rank test, two-tailed was 
used for comparing paired observations. Spearman p (rho) 
were used to estimate the correlation of IL-l/? and IL-lra 
with exposure and health effects. Correlation for multiple 
comparisons was made with the Bonferroni method. Data 
were expressed as median (25th-75th percentile) or 
mean f SEM unless otherwise stated. 
Results 
The concentration of inhalable dust in the swine house 
during exposure was 23 (20-30) mg mp3. The concen- 
tration of respirable dust (n = 8) was 1.0 (0.7-l ‘2) mg m - 3. 
TABLE 1. Lung function and oral temperature before and 
7 h after the start of exposure to swine dust in 36 healthy 
subjects (median, 25th-75th percentiles) 
Before 
exposure 
After 
exposure 
FEV, (1) 3.8 (3.54.9) 3.6 (3.34.6)* 
vc (1) 4.8 (4.3-6.0) 4.6 (4.1l5.8)* 
PD2,FEVl (mg) 2.7 (1.1-11.2) 0.3 (0.1-0.7)* 
Temperature (“C) 36.2 (36-36.5) 36.7 (36.5-37.1)* 
*p<o.o1. 
The concentration of endotoxin (inhalable dust fraction) 
was 1.1 (0.8-1.4)pgmp3. 
The oral temperature increased 0.5 (0.5-0.6) “C at 7 h after 
the start of exposure. Five subjects had an oral temperature 
above 38°C at 9 h or later after the start of exposure. 
FEV, fell by 6% and VC by 3% compared to the 
pre-exposure value (PcO.01). PD,,FEV, for methacholine 
fell from 2.7 (1.1-11.2) to 0.3 (0.1-0.7) mg (P<O.OOl). The 
lung function, challenge test and temperature are shown in 
Table 1. 
LEUKOCYTES IN BLOOD 
The concentration of granulocytes in peripheral blood 
increased in all subjects after exposure and reached maxi- 
mum levels at 7 h after start of exposure. Peripheral blood 
monocytes increased, but lymphocytes decreased (Table 2). 
In the mononuclear cell fraction (n=8), the number of 
lymphocytes decreased from 2.3 & 0.2 to 1.6 5 0.2 x lo9 
cells 1~ ’ and the monocytes increased from 0.5 & 0.1 to 
0.7 & 0.1 x 10’ cells 1~ i 7 h after the start of exposure 
(Fig. 1). 
IL-Ira, IL-6 AND TNF-u IN SERUM 
IL-lra increased significantly from 222 (123-297) ng 1 - ’ to 
316 (196446) ng l- ‘, and 547 (398-657) ng 1 - ’ at 4 and 
7 h after the start of exposure, respectively (Fig. 2). 
The IL-6 concentration increased from less than 
1.5 ng 1-i to 14.8 (7.2-25.5), and 18.9 (7.9-34) ng 1-l 
TABLE 2. Leukocyte concentrations in peripheral blood measured with flow cytometry before and 
after exposure to swine dust. Mean * SEM 
Before 
exposure 
Granulocytes x lo9 cells 1~ i 2.3hO.l 
Lymphocytes x 10’ cells l- ’ 1.7 f 0.1 
Monocytes x lo9 cells 1 - ’ 0.35 f 0.02 
*P<O.OOl compared with pre-exposure values. 
After exposure 
7h 24 h 
6.6 f 0.3* 3.9 f 0.2* 
1.4*0.1* 1.5*0.1* 
0.51 f 0.03* 0.39 f 0.02 
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Before 4h 7h 
After exposure 
FIG. 1. Percent lymphocytes (0) and monocytes (0) in 
the PBMC fraction before, and 4 and 7 h after, the start 
of 3 h exposure to swine dust. Mean f SEM (n=8). 
*P<O.O2 compared with pre-exposure values. 
at 4 and 7 h after the start of exposure, respectively 
(Fig. 2). 
The TNF-a concentration increased from 1.8 (1.4 
2.7) ng 1~ ’ to 3.4 (2.1l52), and 2.5 (1.6-3.3) ng l- ’ at 4 
and 7 h after the start of exposure, respectively (Fig. 2). All 
changes were statistically significant at P<O.Ol. 
IL-l/? in PBMC AND PLASMA 
The concentration of IL-la in PBMC was significantly 
higher at 3, 4 and 7 h but not at 24 h after the start of 
exposure compared to pre-exposure values (Fig. 3). Detect- 
able levels of IL-lfi were found in platelet-poor plasma at 
4 and 7 h after the start of exposure, but not prior to 
exposure (Table 3). 
CORRELATIONS 
Endotoxin in inhaled dust correlated with increase in IL-lp 
in the PBMC fraction (Spearman ~0.64, PcO.05). The 
concentration of respirable dust correlated with increase in 
IL-l/l in plasma (Spearman p 0.96, P<O.O08, n=S). 
IL-lra in serum correlated negatively with PD,,FEV,, 
and positive with temperature changes, leukocyte count 
(Table 4, and TNF-a (Spearman p 0.74, P<O.OOl) and IL-6 
(Spearman p 0.62, P<O.OOS) in peripheral blood. 
Discussion 
Inhalation of swine confinement building dust induces not 
only a local inflammation in the airways, but also systemic 
symptoms and signs including fever and malaise, rise in 
acute phase proteins and peripheral blood granulocytes 
(1,4). These findings suggest increased blood concentrations 
of proinflammatory cytokines, like IL-l, IL-6 and TNF-a. 
In previous communications we have reported an early 
appearance of TNF-a in peripheral blood, and an IL-6 
response with a slower and more protracted time course. 
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FIG. 2. TNF-a (n=21), IL-6 (n=32), and IL-lra (n=36) in 
4h 7h 
serum before and after exposure to swine dust. *P<O.OOl 
After exposure 
compared with pre-exposure values. Horizontal bars 
denote median value. 
We did not mention IL-l, since we were unable to demon- 
strate it in peripheral blood. However, due to methodologi- 
cal improvements we can now report increased, but still 
rather low levels of IL-l/?, in peripheral blood of volunteers 
exposed to swine dust. We also report an increase in IL-lra 
in peripheral blood. 
We tested three methods for the analysis of IL-l/3 in 
blood: the chloroform extraction method, use of fresh 
platelet-poor plasma (13) and separation of peripheral 
blood mononuclear cells (14). IL-l@ was measured with an 
amplified ELISA method. The chloroform method gave the 
same results (not reported) as the platelet-poor plasma 
method. 
A delay in the separation of plasma from blood or 
platelets from plasma may interfere with the analysis of 
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I I I 
Before 3h4h 7h 
FIG. 3. IL-lp concentration in the PBMC fraction at dif- 
ferent times after exposure to swine dust (Ficoll-Paque 
method). *P<O.Ol compared with pre-exposure values. 
Mean f SEM. 
TABLE 3. IL-lp in PBMC (n= 16) and in platelet-poor 
plasma (n = S), median (25th-75th percentiles) 
Before 
exposure 
After exposure 
4h 7h 
PBMC (ng 1 - ‘) 1.6 2.5 
(1.2-1.8) (1.8-3.2)* (l-1:.4)* 
Plasma (ng 1~ ‘) <0.125 0.7 (0409)* 0.9 (0.5-1.3)* 
*P<O.Ol compared with pre-exposure values. 
TABLE 4. Correlations between changes in IL-lra (n=36) in 
serum or IL-IF (n= 16) in PBMC 7 h after start of exposure 
and change in lung function, oral temperature and leuko- 
cytes in peripheral blood 
IL-lra IL-1p 
P pt P P 
FEV, - 0.55 0.002** - 0.61 0.042 
PD,,FEV, - 0.56 0.001** - 0.54 0.047 
Temperaturet 0.71 <0.001** 0.77 0.011* 
Granulocytes 0.52 0.012* 0.63 0.036 
p, Spearman rho. 
TAccording to the Bonferroni correction, P<O.O125 is 
required for significance at the 5% level and P<O.O025 at 
the 1% levels. 
n=32. 
IL-l, due to clotting factors and proteolytic enzymes 
(15,16). We therefore used freshly prepared platelet-poor 
plasma. The level of IL-1B in plasma was below the 
detection limit of the amplified assay in samples collected 
before exposure. After exposure however, we observed a 
small increase of IL-lfi in plasma into the range where it 
could be measured. These levels are compatible with 
results reported by other authors using the same assay in 
studies on patients with silicon implants or with ovarian 
stimulation syndrome (17,18). 
The PBMC fraction, that was freeze-thawed twice in 
order to release intracellular IL-l/3, and had about four 
times higher concentration of IL-lp compared with plasma. 
The plasma and PBMC fraction values are, therefore, 
difficult to compare. The contribution of intracellular IL-l/I 
may have increased the concentration of IL-lb in the 
PBMC fraction (19). The presence of soluble IL-l receptor 
in plasma may have resulted in lower availability of 
immunoreactive IL-lfi in the plasma fraction (20). 
The increase in IL-lb in the PBMC fraction was modest 
(about 70%). Since the number of monocytes in peripheral 
blood also increased about 50%, part of the change in IL-1B 
in the PBMC fraction might be accounted for by the 
presence of more monocytes containing IL-lp, rather than 
by increased IL-l synthesis. On the other hand, the increase 
in IL-lb in platelet-poor plasma suggests a true increase in 
secretion of IL-lp. This is also anticipated since TNF-a 
induces IL-l/3 production in monocytes and there was a 
clear increase in serum TNF-a that clearly preceded maxi- 
mum values for IL-lp (21). The correlation between 
increased endotoxin concentration in respirable dust and 
IL-lp in plasma suggest that the changes were induced by 
some agent(s) in the swine house air. 
We noted an almost 200-fold higher concentration of 
IL-lra in serum compared to IL-l/3, which should be 
sufficient to block many of the effects of IL-l/?. Intravenous 
infusion of endotoxin or IL-l induces a lo- to 40-fold excess 
of IL-lra over IL-lp (22). Thus it is possible that other 
agents cause part of the IL-lra excess, such as IL-6 or 
GM-CSF (granulocyte macrophageecolony stimulate fac- 
tor) (not measured), which are known to release IL-lra, but 
not IL-lp (23). 
The data gives little support to the concept that inhaled 
endotoxin may reach the peripheral circulation, since this 
should have induced a more intense activation of blood 
monocytes, and caused a clear increase in IL-lp (24). 
TNF-a and IL-6 are probably important mediators of the 
peripheral effects observed after inhalation of swine dust 
(25,26). The role of IL-lp in peripheral blood is uncertain. 
Thus the concentration of IL-l/3 was low, and the concen- 
tration of IL-lra was high, but perhaps even very low 
concentrations of IL-lp may induce significant effects in 
co-operation with other cytokines. 
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